[1]
|
Berndorff, D., Gessner, R., Kreft, B., Schnoy, N., Lajous-Petter, A.M., Loch, N., Reutter, W., Hortsch, M. and Tauber, R. (1994) Liver-Intestine Cadherin: Molecular Cloning and Characterization of a Novel Ca2+-Dependent Cell Adhesion Molecule Expressed in Liver and Intestine. Journal of Cell Biology, 125, 1353-1369.
https://doi.org/10.1083/jcb.125.6.1353
|
[2]
|
Gul, I.S., Hulpiau, P., Saeys, Y. and van Roy, F. (2017) Evolution and Diversity of Cadherins and Catenins. Experimental Cell Research, 358, 3-9. https://doi.org/10.1016/j.yexcr.2017.03.001
|
[3]
|
潘地铃. CDH17在肿瘤发生发展中的作用[J]. 中国医疗前沿, 2012, 7(8): 10-11.
|
[4]
|
Kreft, B., Berndorff, D., Böttinger, A., Finnemann, S., Wedlich, D., Hortsch, M., Tauber, R. and Gessner, R. (1997) LI-Cadherin-Mediated Cell-Cell Adhesion Does Not Require Cytoplasmic Interactions. Journal of Cell Biology, 136, 1109-1121. https://doi.org/10.1083/jcb.136.5.1109
|
[5]
|
Nollet, F., Kools, P. and van Roy, F. (2000) Phylogenetic Analysis of the Cadherin Super Family Allow Sidentification of Six Major Subfamilies Besides Several Solitary Members. Journal of Molecular Biology, 299, 551-572.
https://doi.org/10.1006/jmbi.2000.3777
|
[6]
|
Marshall, J.F. (2018) Targeting CDH17 in Cancer: When Blocking the Ligand Beats Blocking the Receptor? Clinical Cancer Research, 24, 253-255. https://doi.org/10.1158/1078-0432.CCR-17-2823
|
[7]
|
Lee, H.J., Nam, K.T., Park, H.S., Kim, M.A., Lafleur, B.J., Aburatani, H., Yang, H.K., Kim, W.H. and Goldenring, J.R. (2010) Gene Expression Profiling of Metaplastic Lineages Identifies CDH17 as a Prognostic Marker in Early Stage Gastric Cancer. Gastroenterology, 139, 213-25.e3. https://doi.org/10.1053/j.gastro.2010.04.008
|
[8]
|
左婷婷, 郑荣寿, 曾红梅, 张思维, 陈万青. 中国胃癌流行病学现状[J]. 中国肿瘤临床, 2017, 44(1): 52-58
|
[9]
|
Becker, K.F., Atkinson, M.J., Reich, U., Huang, H.-H., Nekarda, H., Siewert, J.R., et al. (1993) Exon Skipping in the E-Cadherin Gene Transcript in Metastatic Human Gastric Carcinomas. Human Molecular Genetics, 2, 803-804.
https://doi.org/10.1093/hmg/2.6.803
|
[10]
|
Ito, R., Oue, N., Yoshida, K., Kunimitsu, K., Nakayama, H., Nakachi, K. and Yasui, W. (2005) Clinicopathological Significant and Prognostic Influence of Cadherin-17 Expression in Gastric Cancer. Virchows Archiv, 447, 717-722.
https://doi.org/10.1007/s00428-005-0015-2
|
[11]
|
Wong, B.W., Luk, J.M., Ng, I.O., Hu, M.Y., Liu, K.D. and Fan, S.T. (2003) Identification of Liver-Intestine Cadherin in Hepatocellular Carcinoma—A Potential Disease Marker. Biochemical and Biophysical Research Communications, 311, 618-624. https://doi.org/10.1016/j.bbrc.2003.10.032
|
[12]
|
Long, Z.W., Zhou, M.L., Fu, J.W., Chu, X.Q. and Wang, Y.N. (2015) Association between Cadherin-17 Expression and Pathological Characteristics of Gastric Cancer: A Meta-Analysis. World Journal of Gastroenterology, 21, 3694- 3705. https://doi.org/10.3748/wjg.v21.i12.3694
|
[13]
|
Park, S.S., Kang, S.H., Park, J.M., Kim, J.H., Oh, S.C., Lee, J.H., Chae, Y.S., Kim, S.J., Kim, C.S. and Mok, Y.J. (2007) Expression of Liver-Intestine Cadherin and Its Correlation with Lymph Node Metastasis in Gastric Cancer: Can It Predict N Stage Preoperatively? Annals of Surgical Oncology, 14, 94-99. https://doi.org/10.1245/s10434-006-9114-9
|
[14]
|
Li, R., Yang, H.Q., Xi, H.L., Feng, S. and Qin, R.H. (2017) Inhibition of CDH17 Gene Expression via RNA Interference Reduces Proliferation and Apoptosis of Human MKN28 Gastric Cancer Cells. International Journal of Oncology, 50, 15-22. https://doi.org/10.3892/ijo.2016.3783
|
[15]
|
Liu, L.X., Lee, N.P., Chan, V.W., Xue, W., Zender, L., Zhang, C., Mao, M., Dai, H., Wang, X.L., Xu, M.Z., Lee, T.K., Ng, I.O., Chen, Y., Kung, H.F., Lowe, S.W., Poon, R.T., Wang, J.H. and Luk, J.M. (2009) Targeting Cadherin-17 Inactivates Wnt Signaling and Inhibits Tumor Growth in Liver Carcinoma. Hepatology, 50, 1453-1463. Erratum in: Hepatology, 2010, 51, 358. https://doi.org/10.1002/hep.23143
|
[16]
|
Qu, L.P., Zhong, Y.M., Zheng, Z. and Zhao, R.X. (2017) CDH17 Is a Downstream Effector of HOXA13 in Modulating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer. European Review for Medical and Pharmacological Sciences, 21, 1234-1241.
|
[17]
|
Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. Lancet, 362, 1907-1917.
https://doi.org/10.1016/S0140-6736(03)14964-1
|
[18]
|
Lee, N.P., Poon, R.T., Shek, F.H., Ng, I.O. and Luk, J.M. (2010) Role of Cadherin-17 in Oncogenesis and Potential Therapeutic Implications in Hepatocellular Carcinoma. Biochimica et Biophysica Acta, 1806, 138-145.
https://doi.org/10.1016/j.bbcan.2010.05.002
|
[19]
|
Wang, X.Q., Luk, J.M., Leung, P.P., Wong, B.W., Stanbridge, E.J. and Fan, S.T. (2005) Alternative mRNA Splicing of Liver Intestine-Cadherin in Hepatocellular Carcinoma. Clinical Cancer Research, 11, 483-489.
|
[20]
|
Wang, Y., Shek, F.H., Wong, K.F., Liu, L.X., Zhang, X.Q., Yuan, Y., Khin, E., Hu, M.Y., Wang, J.H., Poon, R.T., Hong, W., Lee, N.P. and Luk, J.M. (2013) Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma. PLoS ONE, 8, e72386. https://doi.org/10.1371/journal.pone.0072386
|
[21]
|
Qiu, H.B., Zhang, L.Y., Ren, C., Zeng, Z.L., Wu, W.J., Luo, H.Y., Zhou, Z.W. and Xu, R.H. (2019) Correction: Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling. PLoS ONE, 14, Article ID: e0217124. Erratum for: PLoS ONE, 2013, 8, Article ID: e56959.
https://doi.org/10.1371/journal.pone.0217124
|
[22]
|
Han, Z., Huang, X.D., Liu, M., Tan, J., Zhu, Q.X., Wang, Y.F., Cai, Y.S., Chen, A.F. and Tian, X. (2017) Knock-Down of Cadherin 17 Inhibits Proliferation and Promote Apoptosis in Noscapine-Resistant Human SW480 Colon Cancer Cells. Chinese Journal of Cellular and Molecular Immunology, 33, 606-610.
|
[23]
|
Kwak, J.M., Min, B.W., Lee, J.H., Choi, J.S., Lee, S.I., Park, S.S., Kim, J., Um, J.W., Kim, S.H. and Moon, H.Y. (2007) The Prognostic Significance of E-Cadherin and Liver Intestine-Cadherin Expression in Colorectal Cancer. Diseases of the Colon & Rectum, 50, 1873-1880. https://doi.org/10.1007/s10350-007-9034-1
|
[24]
|
Ratto, C., Sofo, L., Ippoliti, M., Merico, M., Doglietto, G.B and Crucitti, F. (1998) Prognostic Factors in Colorectal Cancer. Literature Review for Clinical Application. Diseases of the Colon & Rectum, 41, 1033-1049.
https://doi.org/10.1007/BF02237397
|
[25]
|
Takamura, M., Ichida, T., Matsuda, Y., Kobayashi, M., Yamagiwa, S., Genda, T., Shioji, K., Hashimoto, S., Nomoto, M., Hatakeyama, K., Ajioka, Y., Sakamoto, M., Hirohashi, S. and Aoyagi, Y. (2004) Reduced Expression of Liver-Intes- tine Cadherin Is Associated with Progression and Lymph Node Metastasis of Human Colorectal Carcinoma. Cancer Letters, 212, 253-259. https://doi.org/10.1016/j.canlet.2004.03.016
|
[26]
|
Ivanov, D.B., Philippova, M.P. and Tkachuk, V.A. (2001) Structure and Functions of Classical Cadherins. Biochemistry (Moscow), 66, 1174-1186. https://doi.org/10.1023/A:1012445316415
|
[27]
|
Takamura, M., Sakamoto, M., Ino, Y., Shimamura, T., Ichida, T., Asakura, H. and Hirohashi, S. (2003) Expression of Liver-Intestine Cadherin and Its Possible Interaction with Galectin-3 in Ductal Adenocarcinoma of the Pancreas. Cancer Science, 94, 425-430. https://doi.org/10.1111/j.1349-7006.2003.tb01459.x
|
[28]
|
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C.D., Biankin, A.V., Neale, R.E., Tempero, M., Tuveson, D.A., Hruban, R.H. and Neoptolemos, J.P. (2016) Pancreatic Cancer. Nature Reviews Disease Primers, 2, Article No. 16022. https://doi.org/10.1038/nrdp.2016.22
|
[29]
|
Liu, X., Huang, Y., Yuan, H., Qi, X., Manjunath, Y., Avella, D., Kaifi, J.T., Miao, Y., Li, M., Jiang, K. and Li, G. (2019) Disruption of Oncogenic Liver-Intestine Cadherin (CDH17) Drives Apoptotic Pancreatic Cancer Death. Cancer Letters, 454, 204-214. https://doi.org/10.1016/j.canlet.2019.04.022
|
[30]
|
Bhanvadia, S.K. (2018) Bladder Cancer Survivorship. Current Urology Reports, 19, Article No. 111.
https://doi.org/10.1007/s11934-018-0860-6
|
[31]
|
Rao, Q., Williamson, S.R., Lopez-Beltran, A., Montironi, R., Huang, W., Eble, J.N., Grignon, D.J., Koch, M.O., Idrees, M.T., Emerson, R.E., Zhou, X.J., Zhang, S., Baldridge, L.A. and Cheng, L. (2013) Distinguishing Primary Adenocarcinoma of the Urinary Bladder from Secondary Involvement by Colorectal Adenocarcinoma: Extended Immunohistochemical Profiles Emphasizing Novel Markers. Modern Pathology, 26, 725-732.
https://doi.org/10.1038/modpathol.2012.229
|